Endologix Inc.

354 articles about Endologix Inc.

• Endologix Inc. Reports 47% Third Quarter 2009 Revenue Growth Generates $2.7 million in Cash Flow from Operations

  10/28/2009

• Endologix Inc. Responds to Alleged Patent Infringement

  10/14/2009

• Endologix Inc. Comments on Alleged Patent Infringement

  10/9/2009

• Cook Medical Sues Endologix Inc. Over Stent-Grafts

  10/9/2009

• Endologix Inc. to Report Second Quarter 2009 Financial Results on July 22, 2009

  7/10/2009

• Endologix Inc. Announces Live Web Cast of Presentation in SMH Capital Small Cap Spotlight on June 17, 2009 at 4:15 p.m. ET

  6/16/2009

• Endologix Inc. Announces Full Commercial Launch of IntuiTrak Express Delivery System

  6/2/2009

• Endologix Inc. Announces Full Commercial Launch of IntuiTrak Express Delivery System

  6/1/2009

• Endologix Inc. Reports 42% Revenue Growth in the 2009 First Quarter

  4/24/2009

• Endologix Inc. Appoints Vice President of Global Marketing

  4/14/2009

• Endologix Inc. to Hold 2009 First Quarter Financial Results Conference Call on April 23

  4/13/2009

• Endologix Inc. Raises 2009 Revenue Guidance, Now Expects Growth of 25% to 33% over 2008

  3/23/2009

• First Report of Clinical Outcomes Presented from the Endologix Inc. Powerlink Suprarenal Extension Trial

  3/19/2009

• Positive Clinical Data from Endologix Inc. Suprarenal Study to Be Introduced March 19 at SCVS Symposium

  3/13/2009

• Endologix Inc. Announces FDA Approval of the IntuiTrak Express Delivery System

  3/10/2009

• Endologix Inc. Reports 36% Revenue Growth in 2008

  2/20/2009

• Endologix Inc.’s New IntuiTrak Endovascular AAA System Featured at International Congress

  2/10/2009

• Endologix Inc. to Hold 2008 Fourth Quarter and Full Year Financial Results Conference Call on February 19

  2/3/2009

• Endologix Inc. Expects 2008 Total Revenue Growth of 35%; Announces 2009 Financial Guidance

  1/6/2009

• Endologix Inc. Announces Favorable Powerlink XL Clinical Trial Results

  11/20/2008